Article

ROR1 is a novel putative druggable target for diffuse glioma

2021-12-05

Abstract excerpt

The cell surface receptor ROR1 is a therapeutic target of growing interest in oncology; however, its role in glioma has not been established thus far. This study analyzed associations between ROR1 mRNA expression and clinical outcomes, and histological and molecular subtypes in four independent glioma (grades II-IV) transcriptomic datasets (The Cancer Genome Atlas-GBMLGG, Chinese Glioma Genome Atlas, Repository fo...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 02507078-f4dd-590e-a737-a955c66b2802
DOI: 10.1101/2021.12.03.21267166

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

ROR1 is a novel putative druggable target for diffuse gliomaDOI 10.1101/2021.12.03.21267166Read

Comprehensive analysis of predictive significance of PRR11 in glioma at multiple-datasets and single-cell sequencing levelsSemantic proximity Read

Targeting ROR1 identifies new treatment strategies in hematological cancersSemantic proximity Read

Pan-tissue and -cancer analysis of ROR1 and ROR2 transcript variants identify novel functional significance for an alternative splice variant of ROR1Semantic proximity Read

ROR1: an orphan becomes apparentSemantic proximity Read

Ror1 is expressed inducibly by Notch and hypoxia signaling and regulates stem cell‐like property of glioblastoma cellsSemantic proximity Read

ROR1 facilitates glioblastoma growth via stabilizing GRB2 to promote c-Fos expression in glioma stem cellsSemantic proximity Read

IGFBP5 is an ROR1 ligand promoting glioblastoma invasion via ROR1/HER2-CREB signaling axisSemantic proximity Read

Characterization of lymphoma models for the surface ROR1 expressionSemantic proximity Read

Death Receptor 6 as a Prognostic Marker in Low-grade Glioma.Semantic proximity Read

MR1 overexpression correlates with poor clinical prognosis in glioma patientsSemantic proximity Read

DRAXIN as a Novel Diagnostic Marker to Predict the Poor Prognosis of Glioma PatientsSemantic proximity Read

Retinol binding protein 1‐dependent activation of NF‐ κB signaling enhances the malignancy of non‐glioblastomatous diffuse gliomasSemantic proximity Read